BioNona gains FDA approval for Atopis eczema cream, plans to start online US sales

BioNona gains FDA approval for Atopis eczema cream, plans to start online US sales
Jonathan Underhill
By Jonathan Underhill Nov. 29 (BusinessDesk) - BioNona, which markets skin treatment creams developed by biochemist and chief executive Iona Weir, says it has gained US Food and Drug Administration approval for its Atopis eczema cream treatment, giving it access to a market worth as much as US$6 billion. It marks the first such FDA approval for a New Zealand-developed over-the-counter (OTC) pharmaceutical skincare cream and is a culmination of more than 30 years of research and pharmaceutical development by Auckland scientist Weir, whose...